Table 2.
FA** | Body wall (N = 15; n = 3) | Muscle bands (N = 15; n = 3) |
---|---|---|
anteiso-14:0 | 0.88 ± 0.06 | 0.53 ± 0.02 |
14:0 | 1.82 ± 0.04 | 1.13 ± 0.01 |
iso-15:0 | 0.25 ± 0.00 | 0.20 ± 0.00 |
anteiso-15:0 | 1.45 ± 0.03 | 0.61 ± 0.53 |
16:0 | 10.90* ± 0.09 | 6.01 ± 0.06 |
iso-17:0 | 0.87 ± 0.15 | 0.50 ± 0.04 |
anteiso-17:0 | 0.44 ± 0.25 | 0.43 ± 0.01 |
17:0 | 0.95 ± 0.02 | 0.69 ± 0.01 |
18:0 | 6.84* ± 0.05 | 5.70 ± 0.03 |
20:0 | 1.30 ± 0.01 | 1.13 ± 0.01 |
22:0 | 0.60 ± 0.01 | BDL |
24:0 | 0.64 ± 0.32 | 1.21 ± 0.01 |
∑ Saturated FA | 26.94* ± 0.14 | 18.13 ± 0.21 |
16:1n-11 | 0.87 ± 0.15 | 0.50 ± 0.04 |
16:1n-9 | 1.07 ± 0.08 | 0.56 ± 0.01 |
16:1n-7 | 14.99* ± 0.06 | 8.57 ± 0.08 |
16:1n-5 | 1.01 ± 0.01 | 0.58 ± 0.01 |
18:1n-9 cis | 4.96* ± 0.10 | 2.86 ± 0.02 |
18:1n-7 | 5.60 ± 0.03b | 5.80* ± 0.05 |
18:1n-5 | 0.48 ± 0.01 | 0.50 ± 0.01 |
20:1n-11 | 2.56 ± 0.06b | 3.84* ± 0.04 |
20:1n-9 | 2.49* ± 0.19a | 1.59 ± 0.02 |
20:1n-7 | 1.01 ± 0.15a | 1.09 ± 0.05 |
22:1n-9 | 1.30 ± 0.02 | 0.96 ± 0.02 |
22:1n-7 | 1.79 ± 0.03 | 3.60* ± 0.09 |
24:1n-9 | 1.67 ± 0.01 | 1.60 ± 0.05 |
∑ Monounsaturated FA | 39.80* ± 0.16 | 32.05 ± 0.54 |
18:2n-6 cis | 1.04 ± 0.07 | 0.64 ± 0.01 |
18:3n-6 | 1.37 ± 0.02 | 0.42 ± 0.37 |
20:2n-6 | 0.73 ± 0.03 | 1.12 ± 0.01 |
20:4n-6 (ARA) | 7.05 ± 0.03 | 9.90* ± 0.17 |
20:4n-3 | 0.16 ± 0.01 | BDL |
20:5n-3 (EPA) | 12.34 ± 0.04 | 22.63* ± 0.48 |
22:6n-3 (DHA) | 6.19 ± 0.06 | 8.93* ± 0.13 |
∑ Polyunsaturated FA | 28.88 ± 0.06 | 43.64* ± 0.75 |
∑ n-3 | 18.69 ± 0.09 | 31.56* ± 0.61 |
∑ n-6 | 10.19 ± 0.08 | 12.08* ± 0.41 |
Ratio n-3: n-6 | 1.83 ± 0.03 | 2.61* ± 0.12 |
Denotes statistical significance between body wall and muscle bands at P < 0.05.
Statistical analysis conducted only for FA > 2% w/w; BDL, below detection limit = 0.015%; FA, fatty acids.